CARISMA Therapeutics Stock (NASDAQ: CARM) stock price, news, charts, stock research, profile.
Open | $1.700 |
Close | $1.640 |
Volume / Avg. | 54.732K / 166.242K |
Day Range | 1.600 - 1.700 |
52 Wk Range | 1.530 - 9.766 |
Market Cap | $66.468M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 5.09% |
Days to Cover | 9.83 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CARISMA Therapeutics (NASDAQ: CARM) through any online brokerage.
Other companies in CARISMA Therapeutics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Connect Biopharma Hldgs (NASDAQ:CNTB), Aligos Therapeutics (NASDAQ:ALGS), CollPlant Biotechnologies (NASDAQ:CLGN) and Cue Biopharma (NASDAQ:CUE).
The latest price target for CARISMA Therapeutics (NASDAQ: CARM) was reported by BTIG on Thursday, April 11, 2024. The analyst firm set a price target for 6.00 expecting CARM to rise to within 12 months (a possible 275.00% upside). 10 analyst firms have reported ratings in the last year.
The stock price for CARISMA Therapeutics (NASDAQ: CARM) is $1.6 last updated April 26, 2024 at 4:44 PM EDT.
There are no upcoming dividends for CARISMA Therapeutics.
CARISMA Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for CARISMA Therapeutics.
CARISMA Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.